Peer-reviewedCC BYResearch and practice in thrombosis and haemostasis
Novel monoclonal antibodies for an activated protein C cleavage neoepitope of coagulation factor Va
Related
- Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases
- Targeting Integrins in Triple Negative Breast Cancer: Therapeutic Potential of Monoclonal Antibodies, PARP Inhibitors, Synthetic Peptides, and Aptamers
- 83 Translational PBPK modeling of PET imaging reveals enhanced predicted tumor exposure of antiCTLA4 singledomain antibody fragments vs. monoclonal antibodies
- Anti-Nectin4 monoclonal antibodies attenuate airway inflammation and epithelial barrier dysfunction in asthma
- A Multilevel Framework for Evaluating the Impact of Monoclonal Antibodies Against Respiratory Syncytial Virus in Daycare and Households
BibTeX
@article{anon2026novel,
title = {{Novel monoclonal antibodies for an activated protein C cleavage neoepitope of coagulation factor Va}},
journal = {Research and practice in thrombosis and haemostasis},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13656959},
note = {CC BY},
}
RIS
TY - JOUR
TI - Novel monoclonal antibodies for an activated protein C cleavage neoepitope of coagulation factor Va
PY - 2026
DA - 2026/08/01
JO - Research and practice in thrombosis and haemostasis
UR - https://europepmc.org/article/PMC/PMC13656959
SN - 2475-0379
ER -